These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3149148)
1. Carrier detection in hemophilia A: ABO blood group, multiple measurements, and application of logistic discrimination. Percy ME; Rusk AC; Garvey MB; Freedman JJ; Teitel JM; Blake P; Carter C; Andrew M; Johnson M; Inwood M Am J Med Genet; 1988 Dec; 31(4):871-9. PubMed ID: 3149148 [TBL] [Abstract][Full Text] [Related]
2. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865 [TBL] [Abstract][Full Text] [Related]
3. Hemophilia A carrier detection by restriction fragment length polymorphism analysis and discriminant analysis based on ELISA of factor VIII and vWf. Poon MC; Hoar DI; Low S; Pon JK; Anand S; Sinclair GD J Lab Clin Med; 1992 Jun; 119(6):751-62. PubMed ID: 1350611 [TBL] [Abstract][Full Text] [Related]
4. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence. Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499 [TBL] [Abstract][Full Text] [Related]
5. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women. Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307 [TBL] [Abstract][Full Text] [Related]
6. Familial clustering of factor VIII and von Willebrand factor levels. Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584 [TBL] [Abstract][Full Text] [Related]
7. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A. Vlot AJ; Mauser-Bunschoten EP; Zarkova AG; Haan E; Kruitwagen CL; Sixma JJ; van den Berg HM Thromb Haemost; 2000 Jan; 83(1):65-9. PubMed ID: 10669157 [TBL] [Abstract][Full Text] [Related]
8. Remarks on small sample size taken from reference population for examination of factor VIII. Sikorová J; Zvárová J Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):547-51. PubMed ID: 2465970 [TBL] [Abstract][Full Text] [Related]
9. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741 [TBL] [Abstract][Full Text] [Related]
10. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014 [TBL] [Abstract][Full Text] [Related]
11. Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype. Graham JB; Rizza CR; Chediak J; Mannucci PM; Briët E; Ljung R; Kasper CK; Essien EM; Green PP Blood; 1986 Jun; 67(6):1554-9. PubMed ID: 3085743 [TBL] [Abstract][Full Text] [Related]
13. Experience in the laboratory detection of the carrier state of classic hemophilia. Hohn DE; Fisher LM Am J Med Technol; 1979 Apr; 45(4):294-6. PubMed ID: 433979 [TBL] [Abstract][Full Text] [Related]
14. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555 [TBL] [Abstract][Full Text] [Related]
15. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Labarque V; Perinparajah V; Bouskill V; Stain AM; Wakefield C; Manuel C; Blanchette VS; James PD; Lillicrap D; Carcao MD Am J Hematol; 2017 Jun; 92(6):E94-E96. PubMed ID: 28249352 [No Abstract] [Full Text] [Related]
16. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554 [TBL] [Abstract][Full Text] [Related]
17. Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminant. Green PP; Mannucci PM; Briët E; Ljung R; Kasper CK; Essien EM; Chediak J; Rizza CR; Graham JB Blood; 1986 Jun; 67(6):1560-7. PubMed ID: 3085744 [TBL] [Abstract][Full Text] [Related]
18. DNA polymorphisms for carrier detection of hemophilia in Thailand. Chuansumrit A; Goodeve A; Sasanakul W; Peake IR; Pintadit P; Hathirat P; Preston FE; Isarangkul P Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():201-6. PubMed ID: 8629107 [TBL] [Abstract][Full Text] [Related]
19. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion. Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998 [TBL] [Abstract][Full Text] [Related]
20. Bleeding symptoms in carriers of hemophilia A and B. Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]